Who is eligible for clinical trial NCT05205967?

Participants must meet protocol criteria for Early Detection of Cancer. Confirm exact inclusion and exclusion requirements with the study coordinator.

Does clinical trial NCT05205967 provide travel or cost reimbursement?

Check with the site coordinator at the participating facility for travel and lodging stipend availability, and for which routine-care costs are covered.

🏛️ Verified NIH Record • Updated 2025-11-20

REFLECTION: A Clinical Practice Learning Program for Galleri® (NCT05205967)

🔵 Active, Not Recruiting Interventional Protocol 📊 Observational Clinical Research Sponsor: GRAIL, Inc.

🩺 Plain-English Summary (8th-Grade Level)

REFLECTION is a multi-center, prospective, non-interventional, cohort study that will enroll approximately 14,000 individuals who have opted to be screened with Galleri®, a blood-based, multi-cancer early detection (MCED) test in routine clinical settings. The purpose of the study is to understand the real-world experience of Galleri® in clinical settings.

Who can join: To join this study, participants generally need to meet the listed inclusion criteria (5 items) and avoid the listed exclusions (2 items).

Location: Vincere Cancer Center — Scottsdale, Arizona

📋 "Do I Qualify?" — 1-Minute Self Screener

Instant Checklist

Check every box below. If you can check all of them, you may meet the study's basic screening requirements (final eligibility is confirmed by the site team).

Participants are eligible to be included in the study only if all of the following criteria apply:
Participant has the ability to understand and the willingness to sign a written informed consent form (ICF);
Participant is at least 22 years old at the time of consent;
A provider or their designee has ordered the Galleri® test; and
Participant has the ability to comprehend the participant questionnaires.

Usually NOT eligible if any of the following apply:

Exclusion Criteria:
There are no exclusions

🔍 Extracted verbatim from the official NIH eligibility criteria. Always confirm with the study coordinator.

📍 All Participating Trial Locations (16 Sites)

Vincere Cancer Center — Scottsdale, Arizona
Providence — Burbank, California
Providence, St. Jude — Fullerton, California
Providence, Mission — Mission Viejo, California
Providence, Orange County — Orange, California
VA Miami Health Care System — Miami, Florida
James A. Haley Veterans Hospital (VA Tampa) — Tampa, Florida
Southeast Louisiana Veterans Health Care System (SLVHCS) (VA New Orleans) — New Orleans, Louisiana
Boston VA Research Institute (VA Boston) — Boston, Massachusetts
Providence — Portland, Oregon
VA Pittsburgh Healthcare System — Pittsburgh, Pennsylvania
VA Wilkes Barre Medical Center — Wilkes-Barre, Pennsylvania
Carolina Blood and Cancer Care Associate — Lancaster, South Carolina
Carolina Blood and Cancer Care Associates — Rock Hill, South Carolina
VA Salt Lake City Health Care System (VASLCHCS) — Salt Lake City, Utah
WVU University Town Centre Family Medicine — Morgantown, West Virginia

💰 Cost, Insurance & Patient Rights

100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
Voluntary Participation: You may withdraw at any time without affecting your standard medical care.

🏛️ View Official NIH Record ↗